SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Super Micro Computer, Inc. engages in the distribution and manufacture of information technology solutions and other computer products. Its products include twin solutions, MP servers, GPU and coprocessor, MicroCloud, AMD solutions, power supplies, SuperServer, storage, motherboards, chassis, super workstations, accessories, SuperRack and server management products. The company was founded by Charles Liang, Yih-Shyan Liaw, Sara Liu, and Chiu-Chu Liu Liang in September 1993 and is headquartered in San Jose, CA.

Super Micro Computer Inc

Super Micro Computer Inc. is experiencing intense volatility and downward pressure following the announcement of a $7 billion equity financing plan intended to address a massive $39 billion backlog of AI server orders. While some community members view the capital raise as a necessary step to fuel hyper-growth and secure inventory, many investors are expressing deep frustration and suspicion, citing concerns over potential shareholder dilution, ongoing management credibility issues, and the company's aggressive capitalization strategy.

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+, and TMTG News. It operates through the Media and Truth.Fi segments. The Media segment includes products and services such as advertisement through the Truth Social platform. The Truth.Fi segment relates to customized exchange-traded funds or exchange-traded products invested in America First principles, and bitcoin and similar cryptocurrencies or crypto-related securities. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

Trump Media & Technology Group Corp. is trending as the community debates the platform's financial volatility alongside aggressive market reactions to geopolitical escalation in the Middle East. Investors are actively discussing the impact of regional conflicts on inflation and energy prices, while skepticism regarding executive leadership and potential stock performance remains high among critics.

Oracle Corp. engages in the provision of products and services that address aspects of corporate information technology environments, including applications and infrastructure technologies. It operates through the following business segments: Cloud and License, Hardware, and Services. The Cloud and License segment markets, sells, and delivers enterprise applications and infrastructure technologies through cloud and on-premise deployment models including cloud services and license support offerings. The Hardware segment provides infrastructure technologies including Oracle Engineered Systems, servers, storage, industry-specific hardware, operating systems, virtualization, management, and other hardware-related software. The Services segment offers consulting, advanced support, and education services. The company was founded by Lawrence Joseph Ellison, Robert Nimrod Miner, and Edward A. Oates on June 16, 1977 and is headquartered in Austin, TX.

Oracle Corp.

Oracle is facing significant investor volatility as sentiment splits between a record-breaking contract backlog and concerns over the company's aggressive debt-fueled capital expenditure plans for AI infrastructure. The community is actively debating whether the stock's recent pullback represents a strategic buying opportunity or a warning sign of long-term dilution and potential over-leverage.

Rocket Lab Corp. engages in the development of rocket launch and control systems for the space and defense industries. It operates through the Launch Services and Space Systems segments. The Launch Services segment provides launch services to customers on a dedicated mission or ride-share basis. The Space Systems segment consists of spacecraft engineering and design services, spacecraft components, spacecraft manufacturing, and on-orbit mission operations. The company was founded by Peter Beck in 2006 and is headquartered in Long Beach, CA.

Rocket Lab Corp.

Rocket Lab USA Inc

Rocket Lab is currently at the center of investor focus as the market gears up for the historic SpaceX IPO, with community sentiment split between those viewing the event as a catalyst for sector-wide valuation re-ratings and others bracing for short-term volatility or rotation. Discussions are heavily centered on the potential for institutional capital flows to benefit high-quality public space pure-plays like RKLB, even as traders debate technical support levels amid broader market macro pressure.

Alibaba Group Holding Ltd. engages in providing technology infrastructure and marketing reach. It operates through the following business segments: China Commerce, International Commerce, Local Consumer Services, Cainiao, Cloud, Digital Media and Entertainment, and Innovation Initiatives and Others segments. The Core Commerce segment consists of platforms operating in retail and wholesale. The China Commerce segment includes China commerce retail and wholesale businesses. The International Commerce segment focuses on international commerce retail and wholesale businesses. The Local Consumer Services segment is involved in To-Home businesses, which include Ele.me, local services and delivery platform, and Taoxianda, and To-Destination segment businesses which include Amap, the provider of mobile digital map, navigation and real-time traffic information, and restaurant and local services guide platform. The Cainiao segment has Cainiao Network and offers domestic and international one-stop-shop logistics services and supply chain management solution. The Cloud segment includes Alibaba Cloud and DingTalk. The company was founded by Chung Tsai and Yun Ma on June 28, 1999 and is headquartered in Hangzhou, China.

Alibaba Group Holding Ltd - ADR

Alibaba Group Holding Ltd

Alibaba is experiencing extreme volatility as investors debate the impact of potential U.S. defense-related restrictions and ongoing competitive price wars, with many community members expressing frustration over consistent selling pressure. While some traders view current price levels as an attractive entry point for a long-term rebound, sentiment remains heavily divided between those betting on an AI-driven turnaround and others warning of a structural "value trap."

Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The MedTech segment includes a portfolio of products used in interventional solutions, orthopaedics, surgery, and vision categories. The company was founded by Robert Wood Johnson I, James Wood Johnson, and Edward Mead Johnson Sr. in 1887 and is headquartered in New Brunswick, NJ.

Johnson & Johnson

Johnson & Johnson is currently in the spotlight due to a mix of positive sentiment surrounding its oncology pipeline, specifically the recent FDA approval of Icotyde, and persistent legal headwinds from ongoing talc-related litigation. The community is actively debating the company's long-term growth potential and M&A activity as it shifts focus toward innovative medicine and medtech while navigating massive, high-profile legal liabilities.

PDD Holdings, Inc. is a multinational commerce group that owns and operates a portfolio of businesses. The company aims to bring more businesses and people into the digital economy so that local communities and small businesses can benefit from increased productivity and new opportunities. It has built a network of sourcing, logistics, and fulfillment capabilities, that support its underlying businesses. PDD Holdings was founded by Hua Lin Cai and Zheng Huang in 2015 and is headquartered in Dublin, Ireland.

PDD Holdings Inc - ADR

Pinduoduo Inc.

PDD is currently under pressure as investors weigh mixed quarterly earnings against ongoing regulatory friction and rising competitive intensity in the e-commerce sector. While some traders are pointing to the company's significant cash reserves as a valuation floor, others remain cautious due to the aggressive price-cutting environment and the company's recent volatile interactions with domestic authorities.

Fermi, Inc. engages in the development of energy infrastructure. It intends to develop an energy and data center development campus to support the needs of to-be-built AI infrastructure. The company was founded by Rick Perry, Toby Neugebauer and Griffin Perry on January 10, 2025 and is headquartered in Amrillo, TX.

Fermi Inc

Fermi LLC

Fermi Inc. is currently a focal point for investors speculating on its potential as a major data center and AI infrastructure player, specifically regarding interest in its Project Matador facility. Community discourse is heavily divided, with bulls pointing to the potential for hyperscaler tenant deals and massive power capacity, while bears highlight governance instability, recent executive turnover, and a lack of revenue-generating contracts.

SpaceX

Investors are aggressively liquidating broad market positions to raise capital ahead of the highly anticipated SpaceX IPO, which has attracted record-breaking institutional demand. Market participants are debating whether this massive influx of cash will fuel a long-term rally or if retail investors are becoming exit liquidity for insiders in a historically overvalued debut.

Rumble, Inc. engages in operating an online neutral video platform. It operates through the following geographical segments: United States, Canada, and Other. The company was founded in October 2013 by Chris Pavlovski and is headquartered in Longboat Key, FL.

Rumble Inc - Ordinary Shares - Class A

Rumble Inc

Rumble Inc. is trending as investors focus on the impending finalization of the Northern Data acquisition, which is expected to transform the company into a major independent player in AI infrastructure and cloud computing. The community is actively discussing the stock's potential for a short squeeze, citing record-high short interest and the strategic value of newly acquired data centers and GPU capacity, while waiting for further clarity on government and cloud partnership catalysts.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

KYMR Stock Gains as KT-485 Starts Patient Dosing in HS Study

Kymera shares climb after patient dosing begins in a phase I KT-485 study, triggering a $20 million milestone payment from Sanofi.

Sanofi Ends Late-Stage Study on Neurology Drug Over Weak Results

SNY halts its phase III MOBILIZE study after an interim review finds riliprubart unlikely to deliver sufficient efficacy in refractory CIDP patients.

Sanofi Wins EU Nod for Subcutaneous Sarclisa in Multiple Myeloma

SNY wins EU approval for a subcutaneous Sarclisa option in multiple myeloma, offering faster administration and flexible delivery methods.

Sanofi: EC Approves Sarclisa SC For Multiple Myeloma, First EU Therapy Via On-Body Injector

(RTTNews) - The European Commission has approved Sarclisa (isatuximab) subcutaneous (SC) in combination with standard-of-care regimens for the treatment of patients with multiple myeloma (MM) across all existing indications for Sarclisa intravenous (IV) formulation, Sanofi SA (SN...

Sanofi-Owkin Expand AI Collaboration With New Agentic AI Initiative

Owkin and Sanofi expand their AI partnership with a five-year deal to develop agentic systems aimed at accelerating drug research.read more...

Sanofi Stock Falls 6% in 3 Months: Should You Buy, Sell or Hold?

Sanofi shares slip despite strong growth. However, Dupixent, new launches, pipeline progress and a low valuation support staying invested.

GSK Bets on Specialty Medicines to Drive Long-Term Revenue Growth

GSK's Specialty Medicines business is the company's primary growth driver, supported by HIV leadership, new drug launches and a deep late-stage pipeline.

Regeneron Q1 Earnings Top, Sales Up on Dupixent & Eylea HD Strength (Revised)

REGN tops Q1 estimates with strong Dupixent and Eylea HD growth, but the stock slips as Eylea sales plunge and competition intensifies.

FDA Grants Priority Review to SNY's Filing for Gaucher Disease Drug

Sanofi secures FDA priority review for venglustat in GD3, setting up a November decision on a potential first U.S. therapy for neurological symptoms.

Eli Lilly to Expand Vaccine Pipeline With Three Biotech Buyouts

LLY plans $3.83B in biotech buyouts to expand into vaccines and infectious diseases beyond obesity and diabetes.

Sanofi engages in the research, production, and distribution of pharmaceutical products. It operates through the Biopharma segment, which comprises commercial operations and research, development and production activities relating to the specialty care, general medicines and vaccines franchises plus support and corporate functions, for all geographical territories. The company was founded in 1973 and is headquartered in Paris, France.

Current Price	$43.57
Prev Close	$44.73
Open	$43.41
Dividend Yield	3.64%
50-Day Moving Average	$45.24
Beta	0.31
Avg. Volume	2.61M
PE Ratio	18.17

52-Week High	$52.68
52-Week Low	$42.28
Market Capitalization	$104.75B
EPS (Annual)	$2.41
Price to Book	1.26
Revenue Per Employee	$643,658.13

SNYSanofi-Aventis

Fundamentals

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest SNY News